World-Leading Pharmaceutical Company Selects PROACTIS Purchase-to-Pay
PROACTIS, a global Spend Control and eProcurement provider, today announced a world-leading pharmaceutical company will implement PROACTIS Purchase-to-Pay
as part of a corporate initiative to gain better control and visibility of indirect expenditure on all goods and services.
The company is an established global leader in the development of revolutionary veterinary and animal health medicines with operations across the UK as well as in the United States and Australia. With only manual, paper-based processes in place, the company recognised a need to implement a formal system for managing the purchase-to-pay (P2P) process that would provide full visibility of financial commitments and streamline the whole process from requisition through to payment.
PROACTIS Purchase-to-Pay will be integrated to the organisation's ERP system and enable them to manage the entire P2P process in a way that ensures compliance with established approval policies to avoid unnecessary or inappropriate purchases. Through the use of the online system, the P2P process will be faster and more transparent for employees, provide managers with greater budget control, increase 'cost pipeline' visibility for financial management, speed PO release to suppliers, enable automated receipt and invoice matching, and capture an electronic history of spend activity.